Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Apple’s latest event promised to usher in a new era for the company’s iPads, but what’s missing is cohesion as it gets closer to the developers conference.
A settlement being discussed in a lawsuit against the NCAA and major college conferences could cost billions and pave the way for a compensation model.